Floatz logo

Azacitidine

Essential Thrombocythemia

M.D. Anderson Cancer CenterSmall moleculePhase 1/2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Essential Thrombocythemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Thomas Jefferson University
Phase 2BB
TACROLIMUS
Thomas Jefferson University
Phase 2BB
Ruxolitinib
University of Washington
Phase 2B
Cyclophosphamide
Thomas Jefferson University
Phase 2B
Decitabine
University of Washington
Phase 2B

View all 31 →

Same molecule, other indications

Azacitidine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
73 / 100
View asset →
acute erythroid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →